New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 24, 2014
10:54 EDTVIPS, SOHU, CMCM, JMEI, DANG, WBChina's Weibo, Jumei advance after Citi starts coverage with Buy ratings
Shares of Chinese microblog Weibo (WB) and Chinese online beauty product retailer Jumei International (JMEI) are rising after Citigroup initiated coverage of both stocks with Buy ratings. WEIBO: Citigroup analyst Thomas Chong initiated coverage of Weibo with a Buy rating, saying that the company has established a solid, popular brand. Moreover, the company's ad revenue should rise as more small and medium businesses look to advertise on the website, Chong wrote. Additionally, Weibo is slated to fully launch a payment system for companies in the second half of 2014 and this system should help the company sell more ads, the analyst forecast. He set a $22.60 price target on the shares. JUMEI: Jumei International has executed well by recommending quality products to its customers and is establishing a trustworthy brand, Chong believes. The company has a loyal customer base of more than 10M and it is likely to shift to selling many more higher margin private label and exclusive products, the analyst stated. He set a $32.60 target on the shares. WHAT'S NOTABLE: Chong also initiated coverage of Chinese Internet companies Sohu.com (SOHU), Dangdang (DANG), Cheetah Mobile (CMCM), and Vipshop (VIPS) with Buy ratings today. Sohu provides online games and a search engine, while Dangdang is an e-commerce company specializing in books. Cheetah Mobile sells applications for the mobile Internet and Vipshop is an online discount retailer. PRICE ACTION: In mid-morning trading, Weibo rose 1.4% to $19.58 and Jumei climbed 5.25% to $29.49.
News For WB;JMEI;SOHU;DANG;CMCM;VIPS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
May 21, 2015
16:17 EDTJMEIJumei reports Q1 EPS 11c, consensus 9c
Subscribe for More Information
15:01 EDTJMEINotable companies reporting after market close
Subscribe for More Information
14:40 EDTVIPSVipshop volatility increases on wide price movement
Subscribe for More Information
10:44 EDTJMEIJumei initiated with a Buy at T.H. Capital
Subscribe for More Information
07:58 EDTWBWeibo working with Socialbakers on Facebook Insight product, BI reports
Subscribe for More Information
May 20, 2015
10:29 EDTVIPSOptions with decreasing implied volatility
Options with decreasing implied volatility: ZIOP KING ARIA CTRP WTW VHC XON KERX VIPS JCP
08:43 EDTCMCMNomura to hold a conference
Subscribe for More Information
08:29 EDTCMCMCheetah Mobile price target raised to $42 from $30 at Oppenheimer
Oppenheimer raised its price target on Cheetah after the company reported stronger than expected Q1 results, and it announced its strategic goal to be among the top three global mobile ad platforms. The firm notes that the company's mobile revenue soared sixfold year-over-year in Q1, and the firm thinks the company's Q2 revenue growth guidance of 106%-109% looks conservative. Oppenheimer keeps an Outperform rating on the shares.
05:46 EDTVIPSStocks with implied volatility movement; YHOO VIPS
Subscribe for More Information
May 19, 2015
16:23 EDTCMCMOn The Fly: Top stock stories for Tuesday
Subscribe for More Information
11:59 EDTVIPSOptions with decreasing implied volatilit
Subscribe for More Information
09:22 EDTCMCMOn The Fly: Pre-market Movers
Subscribe for More Information
06:13 EDTCMCMCheetah Mobile sees Q2 revenue $126.6M-$128.2M, consensus $126.97M
Subscribe for More Information
06:12 EDTCMCMCheetah Mobile reports Q1 EPS 9c, consensus 7c
Subscribe for More Information
May 18, 2015
16:21 EDTWBOn The Fly: Top stock stories for Monday
Stocks on Wall Street advanced in Monday trading, sending the Dow Jones Industrial Average and the S&P 500 to new all-time closing highs. The early part of the day saw the market move in a narrow range, but by early afternoon the market punched through its upper range and moved to session highs. The market drifted throughout the afternoon as the news flow was quiet and the trading volume remained light. ECONOMIC EVENTS: In the U.S., the National Association of Home Builders’ confidence index fell 2 points to a reading of 54 in May, missing expectations for a 1 point increase to a reading of 57. COMPANY NEWS: Shares of Apple (AAPL) advanced $1.47, or 1.14%, to $130.24 after noted investor Carl Icahn stated in an open letter to the company's CEO that he thinks other investors, analysts and the news media continue to misunderstand Apple and that its stock is "worth $240 today." Icahn urged Apple CEO Tim Cook to take advantage by launching a "much larger buyback" of the iPhone maker's shares. Separately, FBR Capital analysts Daniel Ives and James Moore wrote this morning in a note to investors that the Street is still underestimating Apple's growth outlook in China. The analysts believe that Apple's China revenue will exceed its revenue from the Americas in fiscal 2017... Endo International (ENDP) slid $4.53, or 5.31%, to $80.82 after the company agreed to pay $8B for privately held Par Pharmaceutical, which will roughly double Endo’s generics revenue and place its generics business among the top five as measured by U.S. sales. MAJOR MOVERS: Among the notable gainers was Ann Inc. (ANN), which surged $7.69, or 19.87%, to $46.40 after agreeing to be acquired by Ascena Retail Group (ASNA) for about $2.15B in cash and stock. Ascena, which agreed to pay $37.34 in cash and 0.68 of a share of its own common stock in exchange for each share of the parent of the Ann Taylor brand, slipped 14c, or 0.99%, to $14.07 after announcing the deal. Also higher was Achillion (ACHN), which rose $1.41, or 14.79%, to $10.98 after the company cancelled its presentation at the UBS Global Healthcare Conference. Conference cancellations often generate speculation as to whether a company is engaged in merger or acquisition talks. Among the noteworthy losers was Eleven Biotherapeutics (EBIO), which dropped $8.29, or 69.26%, to $3.68 after announcing the company’s Phase 3 study of its lead drug candidate, EBI-005, in moderate to severe dry eye disease did not meet either of its two co-primary endpoints. Also lower were shares of Weibo (WB), which fell 87c, or 5.24%, to $15.73 after the shares were downgraded to Hold from Buy at Summit Research. INDEXES: The Dow rose 26.32, or 0.14%, to 18,298.88, the Nasdaq gained 30.15, or 0.6%, to 5,078.44, and the S&P 500 added 6.47, or 0.3%, to 2,129.20.
09:43 EDTWBWeibo downgraded to Hold from Buy at Summit Research
Subscribe for More Information
May 15, 2015
11:31 EDTWBInvestors likely to be slightly cautious on Weibo in near-term, says Piper
Piepr Jaffray says that Weibo's guidance was "relatively weak" due to the timing of its revenue from Alibaba (BABA). However, the firm thinks the acceleration in Weibo's user growth to 38% from 36% is a positive sign, and it keeps a $22 price target and Overweight rating on the shares.
10:09 EDTWBInvestors likely to be slightly cautious on Weibo in near-term, says Piper
Subscribe for More Information
08:41 EDTVIPSVipshop responds to allegations made by short seller
Subscribe for More Information
07:20 EDTVIPSVipshop long-term fundamentals intact, says Brean Capital
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use